We are attending BPI Europe 2024
We are pleased to announce our attendance at the upcoming BPI Europe congress, taking place April 9-12 in Vienna. We’ll be showcasing one of our products for the biomanufacturing industry, our Recombinant Insulin, at booth number 240. Approved by the FDA and EMA, our insulin is a key ingredient in over 100 therapeutic drugs, revolutionizing healthcare […]
Novo Nordisk Pharmatech Annual Report 2023
In many ways, 2023 has been a transformational year where we made significant progress on our Novo Nordisk Pharmatech growth strategy. Our revenue grew significantly to 880 MDKK in net sales and landed 47% higher than 2022 reflecting a good year across all products, and on top of that, we have brought three new products […]
100 years of Novo Nordisk Insulin
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
We expand the production
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
How does Recombinant Insulin differ from animal-derived insulin
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
Securing your end-to-end supply chain
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
Safeguarding your regulatory compliance
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
Take a look inside our cGMP manufacturing facilities
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
Get peace of mind for your full product life cycle
Actylis and Novo Nordisk Pharmatech announce a strategic partnership for the distribution of Benzalkonium Chloride in targeted European countries.
